5,175 drugs to be re-evaluated in 2013

Published: 2012-09-04 06:59:00

Updated: 2012-09-04 06:59:00

The Korea Food and Drug Administration announced last Friday that a total of 5,175 products acting on nervous system will be re-evaluated next year as a regular program to assess their safety and efficacy.

The drugs from eight therapeutic categories include general anesthetics, hypnosedatives,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK